Roberts, Glore & Co’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $425K | Hold |
1,563
| – | – | 0.1% | 162 |
|
|
2026
Q2 | $431K | Sell |
1,563
-15
| -1% | -$4.24K | 0.11% | 163 |
|
|
2026
Q1 | $421K | Sell |
1,578
-30
| -2% | -$8.3K | 0.12% | 145 |
|
|
2025
Q4 | $442K | Sell |
1,608
-61
| -4% | -$17.1K | 0.12% | 144 |
|
|
2025
Q3 | $481K | Sell |
1,669
-110
| -6% | -$32.5K | 0.13% | 137 |
|
|
2025
Q2 | $588K | Sell |
1,779
-185
| -9% | -$59.6K | 0.17% | 116 |
|
|
2025
Q1 | $646K | Hold |
1,964
| – | – | 0.2% | 109 |
|
|
2024
Q4 | $542K | Sell |
1,964
-9
| -0.5% | -$2.87K | 0.16% | 116 |
|
|
2024
Q3 | $683K | Hold |
1,973
| – | – | 0.2% | 106 |
|
|
2024
Q2 | $652K | Hold |
1,973
| – | – | 0.2% | 102 |
|
|
2024
Q1 | $716K | Sell |
1,973
-217
| -10% | -$71.4K | 0.21% | 100 |
|
|
2023
Q4 | $656K | Sell |
2,190
-5
| -0.2% | -$1.46K | 0.2% | 102 |
|
|
2023
Q3 | $628K | Sell |
2,195
-100
| -4% | -$28.5K | 0.21% | 99 |
|
|
2023
Q2 | $644K | Sell |
2,295
-18
| -0.8% | -$4.69K | 0.21% | 101 |
|
|
2023
Q1 | $591K | Buy |
2,313
+155
| +7% | +$45.2K | 0.2% | 105 |
|
|
2022
Q4 | $715K | Sell |
2,158
-233
| -10% | -$73.7K | 0.25% | 91 |
|
|
2022
Q3 | $663K | Hold |
2,391
| – | – | 0.24% | 93 |
|
|
2022
Q2 | $630K | Sell |
2,391
-13
| -0.5% | -$3.35K | 0.21% | 99 |
|
|
2022
Q1 | $576K | Sell |
2,404
-167
| -6% | -$39.1K | 0.17% | 119 |
|
|
2021
Q4 | $590K | Sell |
2,571
-17
| -0.7% | -$3.61K | 0.16% | 119 |
|
|
2021
Q3 | $518K | Buy |
2,588
+60
| +2% | +$13K | 0.16% | 121 |
|
|
2021
Q2 | $599K | Sell |
2,528
-115
| -4% | -$28.7K | 0.18% | 109 |
|
|
2021
Q1 | $639K | Buy |
2,643
+53
| +2% | +$11.8K | 0.2% | 105 |
|
|
2020
Q4 | $539K | Sell |
2,590
-344
| -12% | -$67.5K | 0.18% | 117 |
|
|
2020
Q3 | $497K | Buy |
+2,934
| New | +$516K | 0.18% | 114 |
|
|
2019
Q4 | – | Sell |
-1,395
| Closed | -$212K | – | 178 |
|
|
2019
Q3 | $212K | Buy |
1,395
+124
| +10% | +$20.2K | 0.13% | 132 |
|
|
2019
Q2 | $200K | Buy |
+1,271
| New | +$199K | 0.12% | 138 |
|
|
2019
Q1 | – | Sell |
-1,189
| Closed | -$226K | – | 137 |
|
|
2018
Q4 | $226K | Buy |
+1,189
| New | +$248K | 0.16% | 114 |
|
Other funds holding CI
Roberts, Glore & Co's CI Position: Q3 2026 in Review
Roberts, Glore & Co held its Cigna (CI) position steady in Q3 2026 at 1,563 shares worth $425K. The position accounts for 0.1% of the portfolio, ranked #162.
Roberts, Glore & Co first reported a position in CI in Q4 2018 and has held it in 28 quarters since. The position peaked at $716K in Q1 2024. 1,399 funds tracked by Wall St. Rank hold CI as of Q3 2026.
- Roberts, Glore & Co held 1,563 shares of Cigna worth $425K as of Q3 2026.
- Roberts, Glore & Co left its Cigna share count unchanged in Q3 2026.
- Cigna made up 0.1% of Roberts, Glore & Co's portfolio in Q3 2026, its #162 holding.
- Roberts, Glore & Co first reported a position in Cigna in Q4 2018 and has held it in 28 quarters since.
- Roberts, Glore & Co's Cigna position peaked at $716K in Q1 2024.
- 1,399 funds tracked by Wall St. Rank held Cigna as of Q3 2026.
Based on Roberts, Glore & Co's 13F filing for Q3 2026, filed 13 Nov 2026.